|
|
BSE |
NSE |
|
|
Products & Services > Company Profile > Profit & Loss |
|
| Lupin Ltd | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: | 500257 | | NSE Symbol: | LUPIN | | P/E : | 34.94 | ISIN Demat: | INE326A01037 | | Div & Yield %: | 0.25 | | EPS : | 45.22 | Book Value: | 422.9660038 | | Market Cap (Rs.Cr): | 72010.8 | | Face Value : | 2 | |
|
(Rs. In Crores) |
|
| | | | | | Sales Turnover | 11258.83 | 11771.67 | 11055.93 | 11025.66 | 11356.32 | 10088.18 | Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.60 | Net Sales | 11258.83 | 11771.67 | 11055.93 | 11025.66 | 11356.32 | 10080.58 | Other Income | 210.02 | 216.99 | 129.09 | 475.19 | 291.34 | 131.12 | Stock Adjustments | -120.79 | 242.38 | 81.86 | 28.72 | 147.23 | -84.67 | Total Income | 11348.06 | 12231.04 | 11266.88 | 11529.57 | 11794.89 | 10127.03 | | | | | | | Raw Materials | 4676.90 | 4709.64 | 4264.17 | 4235.99 | 4040.13 | 3389.68 | Power & Fuel Cost | 447.42 | 418.45 | 389.54 | 416.26 | 416.30 | 381.32 | Employee Cost | 1934.14 | 1918.16 | 1695.86 | 1703.22 | 1515.42 | 1441.64 | Other Manufacturing Expenses | 1155.60 | 1209.09 | 1135.79 | 1108.70 | 1050.87 | 1194.38 | Selling & Administrative Expenses | 1797.13 | 1573.22 | 1355.01 | 1557.70 | 1488.58 | 1416.04 | Miscellaneous Expenses | 162.95 | 1976.35 | 253.36 | 884.11 | 479.45 | 86.99 | Less : Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Expenditure | 10174.14 | 11804.91 | 9093.73 | 9905.98 | 8990.75 | 7910.05 | Operating Profit | 1173.92 | 426.13 | 2173.15 | 1623.59 | 2804.14 | 2216.98 | Interest | 98.44 | 73.47 | 40.62 | 52.59 | 35.47 | 33.24 | Gross Profit | 1075.48 | 352.66 | 2132.53 | 1571.00 | 2768.67 | 2183.74 | Depreciation | 548.34 | 514.19 | 502.83 | 518.75 | 426.30 | 389.81 | Profit Before Tax | 527.14 | -161.53 | 1629.70 | 1052.25 | 2342.37 | 1793.93 | Tax | 95.89 | 57.80 | 362.85 | 362.05 | 795.00 | 386.57 | Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax | 6.04 | -30.63 | 8.23 | -37.35 | 8.54 | 62.70 | Reported Net Profit | 425.21 | -188.70 | 1258.62 | 727.55 | 1538.83 | 1344.66 | Extraordinary Items | 14.42 | 30.64 | 41.61 | -425.63 | -205.15 | 30.93 | Adjusted Net Profit | 410.79 | -219.34 | 1217.01 | 1153.18 | 1743.98 | 1313.73 | Adjustment below Net Profit | -1.39 | 2.42 | -7.89 | -135.66 | -46.47 | -68.97 | P & L Balance brought forward | 15032.74 | 15514.10 | 14535.25 | 14227.34 | 12961.06 | 12024.18 | Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Appropriations | 181.85 | 295.08 | 271.88 | 226.30 | 226.08 | 338.81 | P & L Balance carried down | 15274.71 | 15032.74 | 15514.10 | 14592.93 | 14227.34 | 12961.06 | Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 226.04 | Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Equity Dividend % | 200.00 | 200.00 | 325.00 | 300.00 | 250.00 | 250.00 | Dividend Per Share(Rs) | 4.00 | 4.00 | 6.50 | 6.00 | 5.00 | 5.00 | Earnings Per Share-Unit Curr | 9.35 | -4.15 | 27.74 | 16.06 | 34.01 | 29.74 | Earnings Per Share(Adj)-Unit Curr | 9.35 | -4.15 | 27.74 | 16.06 | 34.01 | 29.74 | Book Value-Unit Curr | 404.66 | 399.34 | 409.20 | 385.72 | 378.28 | 349.15 | Book Value(Adj)-Unit Curr | 404.66 | 399.34 | 409.20 | 385.72 | 378.28 | 349.15 |
|
|
|
|
|
|